Clinical trials: Testicular Neoplasms

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

• Active, not recruiting
• Age: 18 years and older
• Phase 2
• Surgery or procedure

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may…

Conditions

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma, Adrenal Gland Pheochromocytoma

Trial name

NCT02834013

Testing

Biospecimen Collection, Computed Tomography, Echocardiography Test

Where

1,007 sites in United States, Guam

Volunteers

798 people

Sponsor

National Cancer Institute (NCI)